When we last covered the topic of the FDA’s intended plans for curbing opioid risk, we felt confident that one thing was for sure – education would likely be a key ingredient of the ultimate implemented solution. As it turns out, our assumption was correct. As we mentioned in our opioid REMS update 2012, on Tuesday, April… Read more »
An interview with Stephen G. Henry about the effect of discussing pain on patient-physician communication in a low-income, black primary care population.
Opioids play an important and omnipresent role in the treatment of moderate to severe acute and chronic pain. The fact of the matter is that in patients with acute pain, such as postoperative pain, opioids are utilized as the first-line treatment at least 98% of the time. Opioids are also recognized as the cornerstone of… Read more »
On September 10, 2013, the Food and Drug Administration (FDA) announced a number of changes that are intended to increase the safety of extended-release and long-acting (ER/LA) opioid medications. This announcement applies to all currently marketed ER/LA opioids, and implements two specific approaches to achieve the goal of combatting “the crisis of misuse, abuse, addiction, overdose, and death” according… Read more »
An interview with Mary Lynn McPherson, PharmD, BCPS, CPE about the American Society of Pain Educators (ASPE).
The basis for the long-term use of opioids in the treatment of cancer pain has been fairly well established. Alternatively, a variety of controversies and differences of opinion have surrounded the use of opioid therapy when treating chronic noncancer pain. Issues range from the scientific basis for efficacy, safe and appropriate use, to health care… Read more »
The arbitration of pain, one of the human body’s natural defense mechanisms, and alleviation of patient suffering present an interesting clinical challenge for the clinician. There are few medical conditions where the input of the patient is as crucial to the desired outcome of therapy as that of the clinician. Indeed, most common ailments appropriately… Read more »
An interview with Debra Weiner, managing partner of Aventine Co., about what is to come at PAINWeek 2013 national pain conference.
Fibromyalgia, short for what is actually fibromyalgia syndrome, is one of those diagnoses that can often present specific challenges to primary healthcare providers, as it is surrounded by a swirl of controversies; some legitimate, some founded in what many consider “old-fashioned thinking”. Admittedly, when the criteria for defining a medical condition is itself a source… Read more »
Globally, it was estimated that a total of 365 million prescriptions were written for opioids in 2005, with 235 million of those written in the United States. A significant proportion of them were for the treatment of chronic pain. In the USA, 20% of prescriptions for opioid therapy were for over 30 days’ duration1. Today,… Read more »